Qures Academy

The ACADEMY will have the responsibility to protect and enhance the competence of the IP., Linked to the QURES Academy will be a combination of leading Academics, Scientists, Researchers, industry specialists, Teachers and Trainers, and other notaries to ensure our continued leadership within this technology. Our Teachers and Trainers will travel as necessary and residential courses will also be available. The Academy, through close involvement with our Licensees, and links with Academia and Industry associations, will allow QURES to monitor, protect and maintain our leadership of HYPOTHIOCYANITE IP.  Quickly we will start clinical work to verify the safety of the molecule and then human clinical trials against one or more conditions. Whilst numerous academic papers have shown excellent safety and efficacy already, we anticipate that regulators will be looking for evidence created using more modern techniques and standards. Some of this work is already being identified and negotiated and the first of several animal and human clinical trials will happen very soon, after the Safety status is confirmed. The ACADEMY will develop methods and equipment for existing, and identify potential new, application areas for Hypothiocyanite.  The company’s future growth and development will be achieved by the work of the ACADEMY.  Management and Company support for the work here, will be vital to our growth.

The acknowledgement of the safety to humans of the technology will make our introduction to all other application and licensees so much easier. CLICK to understand the extent of the efficacy of HYPOTHIOCYANITE against pathogens